Affordable Access

deepdyve-link
Publisher Website

Topical oral 1-tetradecanol complex in the treatment of periodontal diseases in cats.

Authors
  • Lopes Kubitza, Fernanda Maria1
  • Anthony, James Mudie George2
  • 1 Campos de Santo Antonio, Itu, São Paulo, Brazil. , (Brazil)
  • 2 Red Bank Veterinary Hospital, Dentistry and Oral Surgery, Red Bank, NJ, USA.
Type
Published Article
Journal
Journal of feline medicine and surgery
Publication Date
Dec 01, 2019
Volume
21
Issue
12
Pages
1141–1148
Identifiers
DOI: 10.1177/1098612X18820734
PMID: 30652935
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The aim of this study was to evaluate the outcomes of the treatment of chronic periodontal disease with an oral application of tetradecanol complex (1-TDC) in cats. The test group (n = 9) received 1-TDC (525 mg per gel capsule/day) and the placebo group (n = 4) received olive oil (0.25 ml per gel capsule/day) for 6 weeks. Oral treatment with 1-TDC resulted in significant reductions in all parameters of clinical periodontal disease except tooth mobility at 6 weeks. The 1-TDC group exhibited a statistically significant reduction in pocket depth, clinical attachment loss, gingival index and bleeding on probing after treatment at 6 weeks, whereas the placebo group did not show any significant change. Chronic inflammation associated with periodontal diseases leads to periodontal tissue destruction. As a result, modulation of the host response has been included in the treatment protocol for periodontal diseases. Fatty acids present anti-inflammatory properties and are being investigated for use in the treatment and prevention of progressive periodontal diseases.

Report this publication

Statistics

Seen <100 times